drugset / Trial / NCT04859621
Phase II Clinical Trial of Vitamin D3 for Reducing Recurrence of Recurrent Lower Urinary Tract Infections
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study was to initially evaluate the optimal dose, efficacy, and safety of vitamin D3 for reducing recurrence of recurrent urinary tract infections (rUTIs).
Timeline
- Start
- 2021-05-08
- Primary completion
- 2025-04-30
- Completion
- 2025-07-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 2000 iu | Oral |
| Subject | Cholecalciferol | Other / unclassified | 4000 iu | Oral |